Title |
Developmental and pathological angiogenesis in the central nervous system
|
---|---|
Published in |
Cellular and Molecular Life Sciences, April 2014
|
DOI | 10.1007/s00018-014-1625-0 |
Pubmed ID | |
Authors |
Mario Vallon, Junlei Chang, Haijing Zhang, Calvin J. Kuo |
Abstract |
Angiogenesis, the formation of new blood vessels from pre-existing vessels, in the central nervous system (CNS) is seen both as a normal physiological response as well as a pathological step in disease progression. Formation of the blood-brain barrier (BBB) is an essential step in physiological CNS angiogenesis. The BBB is regulated by a neurovascular unit (NVU) consisting of endothelial and perivascular cells as well as vascular astrocytes. The NVU plays a critical role in preventing entry of neurotoxic substances and regulation of blood flow in the CNS. In recent years, research on numerous acquired and hereditary disorders of the CNS has increasingly emphasized the role of angiogenesis in disease pathophysiology. Here, we discuss molecular mechanisms of CNS angiogenesis during embryogenesis as well as various pathological states including brain tumor formation, ischemic stroke, arteriovenous malformations, and neurodegenerative diseases. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 151 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 32 | 21% |
Student > Bachelor | 22 | 15% |
Researcher | 18 | 12% |
Student > Master | 15 | 10% |
Student > Doctoral Student | 9 | 6% |
Other | 14 | 9% |
Unknown | 41 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 15% |
Medicine and Dentistry | 19 | 13% |
Neuroscience | 19 | 13% |
Biochemistry, Genetics and Molecular Biology | 16 | 11% |
Engineering | 7 | 5% |
Other | 23 | 15% |
Unknown | 44 | 29% |